Explore tweets tagged as #ESMOTAT2023
@lillian_siu
Lillian Siu
3 years
@myESMO @AnastasiosStat2 The 3 co chairs getting ready to start #ESMOTAT2023
0
3
23
@lillian_siu
Lillian Siu
2 years
#ESMOTAT2023 starting. Amazing agenda and very excited to see so many attendees from all over the world in this important drug development meeting👏👏👏
0
4
29
@RS_Research_TR
RS Research
3 years
Looking forward to meeting our stakeholders at @myESMO's #ESMOTAT2023! Our Co-Founder & CSO Prof. Rana Sanyal, PhD and Medical Director Gülşah Nomak, MD will present the promising preclinical data for RS-0139, currently in Phase I clinical trial, at Hall Bordeaux.
1
2
11
@RS_Research_TR
RS Research
3 years
We are excited to share our preclinical data on RS-0139, currently in Phase I clinical trial, with the oncology community @myESMO Targeted Anticancer Therapies Congress 2023. #drugdevelopment #targetedtherapies #CureWithASmile #ESMOTAT2023
0
2
10
@EMariamidze
Elene Mariamidze
3 years
Best thing to do on Monday ? Grab lunch and join us for some Theranostics talks in room 341 @rillepihlak @clacardone #ESMOTAT2023 #esmoyoc
0
3
11
@TinaJost4
Tina Jost
3 years
I am glad to present my latest data of #DNArepairinhibitors in combination with radiotherapy in #HNSCC at the #esmotat2023 in #paris. #targetedtherapy #translatradbio
0
2
10
@gulsahnomak11
Gülşah Nomak
3 years
Looking forward to reuniting with esteemed researchers at #ESMOTAT2023, “The Home of Phase I in Oncology” #oncology #preclinical #clinicaltrials @RS_Research_TR @ranasanyal_
@RS_Research_TR
RS Research
3 years
Looking forward to meeting our stakeholders at @myESMO's #ESMOTAT2023! Our Co-Founder & CSO Prof. Rana Sanyal, PhD and Medical Director Gülşah Nomak, MD will present the promising preclinical data for RS-0139, currently in Phase I clinical trial, at Hall Bordeaux.
0
1
5